| 英文名称 | 中文名称 | CAS | MF |
|
Ethanone,1-(2-ethynylcyclohexyl)-
|
|
155222-56-3
|
C10H14O
|
|
Cyclopropane, 1-butoxy-2-ethynyl-, trans- (9CI)
|
|
155223-33-9
|
C9H14O
|
|
Cyclopropane, 1-butoxy-2-ethynyl-, cis- (9CI)
|
|
155223-34-0
|
C9H14O
|
|
2-Piperazinemethanol,4-methyl-,(S)-(9CI)
|
|
155225-18-6
|
C6H14N2O
|
|
Pyrrolo[1,2-a]pyrazine-3-methanol, octahydro-, (3R-trans)- (9CI)
|
Pyrrolo[1,2-a]pyrazine-3-methanol, octahydro-, (3R-trans)- (9CI)
|
155225-19-7
|
C8H16N2O
|
|
2-Piperazinemethanol,5-(1-methylethyl)-,(2R-cis)-(9CI)
|
|
155225-20-0
|
C8H18N2O
|
|
2-Piperazinemethanol,5-(2-methylpropyl)-,(2R-cis)-(9CI)
|
|
155225-21-1
|
C9H20N2O
|
|
CYCLO(-ALA-SER)
|
CYCLO(-ALA-SER)
|
155225-26-6
|
C6H10N2O3
|
|
(Z)-2-(((E)-3,4-dimethoxybenzylidene)hydrazono)thiazolidin-4-one
|
|
155225-31-3
|
C12H13N3O3S
|
|
(+)-3R,5S-FLUVASTATIN SODIUM SALT
|
(3R,5S,6E)-7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羟基-6-庚烯酸
|
155229-75-7
|
C24H26FNO4
|
|
(-)-3S,5R-FLUVASTATIN SODIUM SALT
|
(-)-3S,5R-氟伐他汀钠盐
|
155229-76-8
|
C24H26FNO4
|
|
chrymutasin C
|
酒教突变霉素 C
|
155232-80-7
|
C39H43NO17
|
|
Caloxanthone B
|
Caloxanthone B
|
155233-17-3
|
C24H26O6
|
|
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-
|
|
155233-30-0
|
C23H35NOS
|
|
DK-AH 268
|
|
155233-34-4
|
C28H39ClN2O5
|
|
kneglomeratanol
|
|
155233-36-6
|
C22H30O2
|
|
kneglomeratanone A
|
|
155233-37-7
|
C22H28O3
|
|
kneglomeratanone B
|
|
155233-38-8
|
C21H34O3
|
|
4-Cyclohexene-1,2,3-triol,6-amino-,(1R,2S,3R,6S)-rel-(9CI)
|
|
155239-00-2
|
C6H11NO3
|
|
4-Cyclohexene-1,2,3-triol,6-amino-,(1alpha,2alpha,3beta,6alpha)-(9CI)
|
|
155239-06-8
|
C6H11NO3
|
|
5-Hydroxy-1,7-diphenylhept-6-en-3-one
|
|
155239-30-8
|
C19H20O2
|
|
8-Hydroxy Mirtazapine
|
8-Hydroxy Mirtazapine
|
155239-47-7
|
C23H27N3O7
|
|
1H-Indene-2-acetic acid, a-amino-2,3-dihydro-, (S)-
|
S-茚满基甘氨酸
|
155239-51-3
|
C11H13NO2
|
|
Benzenesulfonic acid, dodecyl-, reaction products with succinic anhydride monopolyisobutylene derivs., tetraethylenepentamine and zinc oxide
|
|
155240-18-9
|
|
|
1H-Benzimidazole,5-methoxy-1-(methoxymethyl)-(9CI)
|
|
155242-61-8
|
C10H12N2O2
|
|
1H-Benzimidazole,6-methoxy-1-(methoxymethyl)-(9CI)
|
|
155242-62-9
|
C10H12N2O2
|
|
1-Benzyl-1,3-benzodiazol-4-aMine
|
1-Benzyl-1,3-benzodiazol-4-aMine
|
155242-92-5
|
C14H13N3
|
|
4-AMINO-1-METHYL BENZIMIDAZOLE
|
1-甲基-1H-苯并[D]咪唑基-4-胺
|
155242-98-1
|
C8H9N3
|
|
Propaneperoxoic acid, methyl ester
|
|
155249-05-1
|
C4H8O3
|
|
(S)-tert-Butyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate
|
(S)-2-(吡咯烷-1-羰基)吡咯烷-1-羧酸叔丁酯
|
155251-70-0
|
C14H24N2O3
|
|
(R)-tert-butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate
|
(2R)-4-氧代-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯
|
155251-72-2
|
C13H22N2O3S
|
|
Cyclopentanone, 3-acetyl-, (R)- (9CI)
|
|
155253-52-4
|
C7H10O2
|
|
Cyclopentanone, 3-acetyl-, (3S)- (9CI)
|
|
155253-53-5
|
C7H10O2
|
|
Hexanal, 4-methylene-5-oxo- (9CI)
|
|
155254-44-7
|
C7H10O2
|
|
4-Amino-5-bromo-2-(trifluoromethyl)benzonitrile
|
4-氨基-5-溴-2-三氟甲基苯腈
|
155255-45-1
|
C8H4BrF3N2
|
|
2-[Methyl(2-phenylacetyl)amino]acetic acid
|
|
155256-51-2
|
C11H13NO3
|
|
Acetic acid, (formylmethylamino)hydroxy- (9CI)
|
|
155256-58-9
|
C4H7NO4
|
|
NOTO
|
NOTO
|
155256-95-4
|
C4N8O4
|
|
2-(Tributylstannyl)-2-propen-1-amine
|
2-(Tributylstannyl)-2-propen-1-amine
|
155258-22-3
|
C15H33NSn
|
|
1,2-DIIODO-4,5-(DIDECYLOXY)BENZENE
|
|
155259-28-2
|
C26H44I2O2
|
|
2H-Pyran,2-ethoxy-3,4-dihydro-6-methyl-4-phenyl-,cis-(9CI)
|
|
155259-37-3
|
C14H18O2
|
|
[9-(DIETHYLAMINO)-5H-BENZO[A]PHENOXAZIN-5-YLIDENE]MALONONITRILE
|
[9-(二乙胺基)-5H-苯并[A]苯并噁嗪-5-亚基]丙二腈
|
155262-39-8
|
C23H18N4O
|
|
4-Thiazolidinecarboxylicacid,hydrazide(9CI)
|
|
155264-41-8
|
C4H9N3OS
|
|
2-Propenethioamide,3-(4-ethoxyphenyl)-(9CI)
|
|
155265-07-9
|
C11H13NOS
|
|
2-Bromo-3-cyano-6-methylpyridine
|
2-溴-3-氰基-6-甲基吡啶
|
155265-57-9
|
C7H5BrN2
|
|
Phenol, 4,4'-(2,5-pyridinediyl)bis-
|
2,5-BIS(4-HYDROXYPHENYL)PYRIDINE
|
155266-51-6
|
C17H13NO2
|
|
Benzene, 4-[4'-(3-butenyl)[1,1'-bicyclohexyl]-4-yl]-1,2-difluoro-, [trans(trans)]-
|
155266-68-5
|
155266-68-5
|
C22H30F2
|
|
DIMETHYL 3-(2-CHLOROACETYL)-1,3-THIAZOLANE-2,4-DICARBOXYLATE
|
|
155266-94-7
|
C9H12ClNO5S
|
|
2H-Pyran-3-carbonyl chloride, 3,4-dihydro- (9CI)
|
|
155268-09-0
|
C6H7ClO2
|
|
(4R)-2-Methyl-4,5,5-triphenyl-1,3,2-oxazaborolidine
|
(4R)-2-甲基-4,5,5-三苯基-1,3,2-恶唑硼烷
|
155268-88-5
|
C21H20BNO
|
|
1-(4-Hydroxyphenyl)-3-(4-isopropylphenyl)prop-2-en-1-one
|
4'-HYDROXY-4-ISOPROPYLCHALCONE
|
155269-25-3
|
C18H18O2
|
|
2-Pyridinemethanol,6-ethenyl-(9CI)
|
|
155269-60-6
|
C8H9NO
|
|
3-(Piperidin-4-yl)propan-1-ol hydrochloride
|
4-哌啶丙醇盐酸盐
|
155270-01-2
|
C8H17NO.HCl
|
|
14,14'-(dithiobis((2-oxo-2,1-ethanediyl)imino))bis(7,8-dihydro-N-(cyclopropylmethyl)normorphinone)
|
|
155270-53-4
|
C44H50N4O8S2
|
|
9-(3,3-dimethyl-5-phosphonopentyl)guanine
|
|
155270-69-2
|
C12H20N5O4P
|
|
Ethanone, 1-(7-azabicyclo[2.2.1]hept-5-en-2-yl)-, endo- (9CI)
|
|
155270-80-7
|
C8H11NO
|
|
Ethanone, 1-(7-azabicyclo[2.2.1]hept-5-en-2-yl)-, exo- (9CI)
|
|
155270-81-8
|
C8H11NO
|
|
8-[(1E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-3,9-dihydro-1H-purine-2,6-dione
|
8-[(1E)-2-(3,4-二甲氧基苯基)乙烯基]-1,3-二乙基-3,9-二氢-1H-嘌呤-2,6-二酮
|
155270-98-7
|
C19H22N4O4
|
|
8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-purine-2,6 -dione
|
伊曲茶碱
|
155270-99-8
|
C20H24N4O4
|
|
8-[(E)-2-(2,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7H-purine-2,6-dione
|
|
155271-02-6
|
C19H22N4O4
|
|
1H-Purine-2,6-dione,3,7-dihydro-8-[(1E)-2-(4-methoxy-2,3-dimethylphenyl)ethenyl]-1,3-dimethyl-(9CI)
|
8-(4-甲氧基-2,3-二甲基苯乙烯基)-1,3-二甲基-1H-嘌呤-2,6(3H,7H)-二酮
|
155271-16-2
|
C18H20N4O3
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(2-chloro-3,4-dimethoxyphenyl)et henyl)-1,3-diethyl-, (E)-
|
|
155271-42-4
|
C19H21ClN4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(2-chloro-3,4-dimethoxyphenyl)et henyl)-1,3-diethyl-7-methyl-, (E)-
|
|
155271-43-5
|
C20H23ClN4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(2-chloro-3,4-dimethoxyphenyl)et henyl)-1,3-dimethyl-, (E)-
|
|
155271-44-6
|
C17H17ClN4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(2-chloro-3,4-dimethoxyphenyl)et henyl)-1,3,7-trimethyl-,(E)-
|
|
155271-45-7
|
C18H19ClN4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(3,4-difluorophenyl) ethenyl)-, (E)-
|
|
155271-46-8
|
C17H16F2N4O2
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(3-bromo-4-methoxyphenyl)ethenyl )-1,3-diethyl-, (E)-
|
|
155271-48-0
|
C18H19BrN4O3
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(3-bromo-4-methoxyphenyl)ethenyl )-1,3,7-trimethyl-, (E)-
|
|
155271-51-5
|
C17H17BrN4O3
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(2-bromo-4,5-dimethoxyphenyl)eth enyl)-1,3-diethyl-, (E)-
|
|
155271-52-6
|
C19H21BrN4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(2-bromo-4,5-dimethoxyphenyl)eth enyl)-1,3-diethyl-7-methyl-, (E)-
|
|
155271-53-7
|
C20H23BrN4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(4,5-dimethoxy-2-nit rophenyl)ethenyl)-7-methyl-, (E)-
|
|
155271-55-9
|
C20H23N5O6
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(3-nitrophenyl)ethen yl)-, (E)-
|
|
155271-82-2
|
C17H17N5O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(2-fluorophenyl)ethe nyl)-, (E)-
|
|
155271-90-2
|
C17H17FN4O2
|
|
(E)-1,3-Diethyl-8-(2-(2-fluorophenyl)ethenyl)-7-methyl-3,7-dihydro-1H- purine-2,6-dione
|
|
155271-91-3
|
C18H19FN4O2
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(7-methoxy-1,3-benzo dioxol-5-yl)ethenyl)-7-methyl-, (E)-
|
|
155272-00-7
|
C20H22N4O5
|
|
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)
|
1H-嘌呤-2,6-二酮,8- [2-(3,4-二羟基苯基)乙烯基] -1,3-二乙基-3,7-二氢-7-甲基-,(E)-(9CI)
|
155272-03-0
|
C18H20N4O4
|
|
3-Desmethyl Istradefylline
|
1H-嘌呤-2,6-二酮,3,7-二氢-1,3-二乙基-8-(2-(3-羟基-4-甲氧基苯基)乙烯基)-7-甲基-,(E)-
|
155272-04-1
|
C19H22N4O4
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(4-hydroxyphenyl)eth enyl)-7-methyl-, (E)-
|
|
155272-05-2
|
C18H20N4O3
|
|
(E)-8-(4-(4-bromobutoxy)styryl)-1,3-diethyl-7-methylxanthine
|
|
155272-07-4
|
C22H27BrN4O3
|
|
1H-Purine-2,6-dione, 3,7-dihydro-8-(2-(4-(4-aminobutoxy)phenyl)ethenyl )-1,3-diethyl-7-methyl-,(E)-
|
|
155272-09-6
|
C22H29N5O3
|
|
Acetic acid, (4-(2-(1,3-diethyl-2,3,6,7-tetrahydro-7-methyl-2,6-dioxo- 1H-purin-8-yl)ethenyl)phenoxy)-, ethyl ester, (E)-
|
|
155272-10-9
|
C22H26N4O5
|
|
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(4-hydroxyphenyl)eth enyl)-, (E)-
|
|
155272-14-3
|
C17H18N4O3
|
|
Pyrazine, 2-(2-furanylmethyl)-3,5-dimethyl- (9CI)
|
|
155272-50-7
|
C11H12N2O
|
|
Pyridinium, 1-(2-((4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)ethyl)-, br omide
|
|
155272-58-5
|
|
|
Quinuclidinium, 3-hydroxy-1-(2-((2-oxo-2H-1-benzopyran-7-yl)oxy)ethyl) -, bromide
|
|
155272-59-6
|
|
|
THIOTOMOXETINE
|
N-甲基-3-(2-(甲硫基)苯氧基)-3-苯基丙烷-1-胺
|
155273-01-1
|
C17H21NOS
|
|
1,8-Diazabicyclo[3.2.1]octane, 7,7-dimethyl-3-methylene-
|
|
155282-10-3
|
C9H16N2
|
|
1-Azabicyclo[2.2.2]octan-3-one,2-(1-methylethyl)-(9CI)
|
|
155282-37-4
|
C10H17NO
|
|
1-Azabicyclo[2.2.2]octane,2-(1-methylethyl)-(9CI)
|
|
155282-38-5
|
C10H19N
|
|
HLA-B59
|
|
155286-92-3
|
|
|
2-(4-(4-(1,2-benzisothiazol-3-yl)piperazin-1-yl)butyl)-1-isoindolinone
|
|
155288-46-3
|
C23H26N4OS
|
|
2-(4-(4-(3-(1,2-benzisothiazolyl))-1-piperazinyl)butyl)-4a,5,6,7,8,8a-hexahydro-1(2H)-phthalazinone
|
|
155289-55-7
|
C23H31N5OS
|
|
2-(2'-N-BOC-HYDRAZINO)BENZOIC ACID
|
2-(2'-N-BOC-HYDRAZINO)BENZOIC ACID
|
155290-47-4
|
C12H16N2O4
|
|
NB 598 Maleate
|
NB-598 马来酸盐
|
155294-62-5
|
C31H35NO5S2
|
|
2-CHLORO-4-(3-METHYLPHENYL)THIAZOLE
|
|
155294-66-9
|
C10H8ClNS
|
|
1-PIVALOYL-PIPERAZINE
|
1 -丙酮,2 -二甲基- 1 -(1 -哌嗪基)
|
155295-47-9
|
C9H18N2O
|
|
1-(4-Bromophenyl)-3,4-dimethylpyrano[2,3-c]pyrazol-6(1H)-one
|
|
155297-20-4
|
C14H11BrN2O2
|
|
Propanoic acid, 3-(hydroxyimino)-2-(methoxyimino)-, methyl ester (9CI)
|
|
155299-39-1
|
C5H8N2O4
|
|
2H-Pyran-2-one, 3-acetyl-6-methyl- (9CI)
|
|
155299-75-5
|
C8H8O3
|
|
3,3'-DIMETHYL-1-(4-PHENY-2-THIAZOLYL)-1'-PHENYL-5-HYDROXY[4,5']-BIPYRAZOL
|
5,5'-二甲基-2-苯基-2'-(4-苯基噻唑-2-基)-1',2'-二氢-2H,3'H-[3,4'-联吡唑]-3'-酮
|
155299-83-5
|
C23H19N5OS
|